INO
Inovio Pharmaceuticals Inc
Price:  
8.86 
USD
Volume:  
452,376.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO EV/EBITDA

-1294.6%
Upside

As of 2024-03-01, the EV/EBITDA ratio of Inovio Pharmaceuticals Inc (INO) is -1.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INO's latest enterprise value is 199.26 mil USD. INO's TTM EBITDA according to its financial statements is -163.13 mil USD. Dividing these 2 quantities gives us the above INO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 10.6x - 14.9x 12.6x
Forward P/E multiples 14.8x - 18.5x 16.9x
Fair Price (105.88) - (106.60) (105.84)
Upside -1295.0% - -1303.1% -1294.6%
8.86 USD
Stock Price
(105.84) USD
Fair Price

INO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-02-29 -1.22
2024-02-28 -1.17
2024-02-27 -1.24
2024-02-26 -1.12
2024-02-23 -1.08
2024-02-22 -1.05
2024-02-21 -1.09
2024-02-20 -1.13
2024-02-16 -1.09
2024-02-15 -1.02
2024-02-14 -1.01
2024-02-13 -0.90
2024-02-12 -0.98
2024-02-09 -0.93
2024-02-08 -0.79
2024-02-07 -0.72
2024-02-06 -0.73
2024-02-05 -0.67
2024-02-02 -0.69
2024-02-01 -0.73
2024-01-31 -0.74
2024-01-30 -0.80
2024-01-29 -0.86
2024-01-26 -0.84
2024-01-25 -0.93
2024-01-24 -0.95
2024-01-23 -0.96
2024-01-22 -1.14
2024-01-19 -1.11
2024-01-18 -1.19
2024-01-17 -1.16
2024-01-16 -1.24
2024-01-12 -1.27
2024-01-11 -1.47
2024-01-10 -1.44
2024-01-09 -1.43
2024-01-08 -1.22
2024-01-05 -1.19
2024-01-04 -0.94
2024-01-03 -0.86
2024-01-02 -0.93
2023-12-29 -0.84
2023-12-28 -0.86
2023-12-27 -0.84
2023-12-26 -0.86
2023-12-22 -0.73
2023-12-21 -0.67
2023-12-20 -0.63
2023-12-19 -0.63
2023-12-18 -0.62